Search Ontology:
ChEBI
pralatrexate
- Term ID
- CHEBI:71223
- Synonyms
-
- (2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid
- (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid
- 10-Propargyl-10-deazaaminopterin
- Folotyn
- HSDB 7786
- N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid
- N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid
- pralatrexate
- pralatrexato
- pralatrexatum
- Definition
- A pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma.
- References
-
- CAS:146464-95-1
- Drug_Central:4117
- KEGG:D05589
- PMID:20622807
- PMID:20669794
- PMID:20702104
- PMID:20739433
- PMID:21179031
- PMID:21245435
- PMID:21417858
- PMID:21591544
- PMID:21726160
- PMID:21841501
- PMID:21939422
- PMID:21956523
- PMID:22076116
- PMID:22343388
- PMID:22362328
- PMID:22394596
- PMID:22457602
- PMID:22534814
- PMID:22542448
- PMID:22789917
- PMID:22921318
- PMID:23008944
- PMID:23032692
- PMID:23040436
- PMID:23115213
- Patent:US2005267117
- Patent:US2011190305
- Patent:US6028071
- Patent:US6323205
- Patent:WO2007023243
- Reaxys:6624234
- Wikipedia:Pralatrexate
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from pralatrexate
Phenotype where environments contain pralatrexate
Phenotype modified by environments containing pralatrexate
Human Disease Model